Bristol Myers Squibb
Executive Director, Early Asset Lead, Worldwide Hematology Commercialization
Bristol Myers Squibb, Princeton, New Jersey, us, 08543
Working with UsChallenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity. Take your career farther than you thought possible.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Description:
The Executive Director, Early Asset Lead will be responsible for providing commercial input into discovery and early development plans for new assets from ID1 (Go to full discovery) to ID4 (Go to full development). The lead will collaborate with early development teams in Hematology as well as the DSTs (Disease Strategy Teams) and Hematology Commercial Strategy to provide input into asset and above asset strategies.
The role will report to Vice President, BD, Strategy and Early Assets. Responsibilities include:
Lead a high-performing Early Assets commercial team to deliver on the key responsibilities of the function
Provide commercial input into vision and strategic fit of asset within Hematology StrategyPrioritize business opportunities and develop target opportunity profiles to guide development decisionsSize asset potential and partner with BI&A to develop forecast (depending on stage of asset)Provide commercial input into potential development paths based on unmet need, competitive intensity, and size of opportunityRepresent early assets on Hematology Strategy Teams to ensure maturing pipeline is fully considered in Disease Area and Portfolio StrategyPartner with Early Development team on above asset discussions / strategies
Creating a high-performing team culture that inspires integrity, urgency, accountability, innovation, passion and inclusionRequirements
BS/BA or equivalent required; an advanced scientific degree preferred10 years of experience in biopharmaceutical or related fieldA unique blend of scientific acumen with demonstrated commercial competencies requiredExperience in mobilizing matrix team members, embracing teamwork and driving results within a cross functional environmentExperience partnering with R&D requiredDemonstrated strategic and analytical agility, with regard to market research, competitive data collection analysis, financial analysis and crystallization of key business insightsStrong interpersonal and communication skills, ability to influence and align stakeholders
#J-18808-Ljbffr
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Description:
The Executive Director, Early Asset Lead will be responsible for providing commercial input into discovery and early development plans for new assets from ID1 (Go to full discovery) to ID4 (Go to full development). The lead will collaborate with early development teams in Hematology as well as the DSTs (Disease Strategy Teams) and Hematology Commercial Strategy to provide input into asset and above asset strategies.
The role will report to Vice President, BD, Strategy and Early Assets. Responsibilities include:
Lead a high-performing Early Assets commercial team to deliver on the key responsibilities of the function
Provide commercial input into vision and strategic fit of asset within Hematology StrategyPrioritize business opportunities and develop target opportunity profiles to guide development decisionsSize asset potential and partner with BI&A to develop forecast (depending on stage of asset)Provide commercial input into potential development paths based on unmet need, competitive intensity, and size of opportunityRepresent early assets on Hematology Strategy Teams to ensure maturing pipeline is fully considered in Disease Area and Portfolio StrategyPartner with Early Development team on above asset discussions / strategies
Creating a high-performing team culture that inspires integrity, urgency, accountability, innovation, passion and inclusionRequirements
BS/BA or equivalent required; an advanced scientific degree preferred10 years of experience in biopharmaceutical or related fieldA unique blend of scientific acumen with demonstrated commercial competencies requiredExperience in mobilizing matrix team members, embracing teamwork and driving results within a cross functional environmentExperience partnering with R&D requiredDemonstrated strategic and analytical agility, with regard to market research, competitive data collection analysis, financial analysis and crystallization of key business insightsStrong interpersonal and communication skills, ability to influence and align stakeholders
#J-18808-Ljbffr